S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT00040937 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: sargramostim
DRUG: cyclophosphamide
DRUG: dexamethasone
DRUG: melphalan
DRUG: prednisone
DRUG: thalidomide
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]